Rxo (RXO) Other financing activities (2022 - 2025)

Rxo (RXO) has reported Other financing activities for 4 consecutive years, with $1.0 million the latest figure, recorded in Q2 2025.

• For the quarter ending Q2 2025, Other financing activities rose 200.0% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (down 99.91% YoY), and the FY2025 full-year result was -$10.0 million, down 100.89% from the prior year.
• Other financing activities advanced to $1.0 million in Q2 2025 per RXO's latest filing, from -$11.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $1.1 billion in Q3 2024 and bottomed at -$11.0 million in Q1 2025.
• Historically, Other financing activities has averaged $123.6 million across 4 years, with a median of -$1.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Other financing activities changed 0.0% in 2023, then surged 112500.0% in 2024.
• Over 4 years, Other financing activities stood at -$2.0 million in 2022, then changed by 0.0% to -$2.0 million in 2023, then jumped by 56400.0% to $1.1 billion in 2024, then plunged by 99.91% to $1.0 million in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered $1.0 million, -$11.0 million, and $1.1 billion for Q2 2025, Q1 2025, and Q3 2024 respectively.